Published in Curr Mol Pharmacol on November 01, 2010
Will new generations of modified antimicrobial peptides improve their potential as pharmaceuticals? Int J Antimicrob Agents (2011) 1.28
Intein applications: from protein purification and labeling to metabolic control methods. J Biol Chem (2014) 1.10
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem (2012) 1.10
Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery. Curr Pharm Des (2011) 1.08
Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways. J Control Release (2011) 1.08
In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. J Am Chem Soc (2013) 1.06
Biological synthesis of circular polypeptides. J Biol Chem (2012) 1.03
Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions. Angew Chem Int Ed Engl (2013) 0.94
The two-step biosynthesis of cyclic peptides from linear precursors in a member of the plant family Caryophyllaceae involves cyclization by a serine protease-like enzyme. J Biol Chem (2013) 0.87
Defining the membrane disruption mechanism of kalata B1 via coarse-grained molecular dynamics simulations. Sci Rep (2014) 0.84
Recombinant Expression and Phenotypic Screening of a Bioactive Cyclotide Against α-Synuclein-Induced Cytotoxicity in Baker's Yeast. Angew Chem Int Ed Engl (2015) 0.82
Asteropsins B-D, sponge-derived knottins with potential utility as a novel scaffold for oral peptide drugs. Biochim Biophys Acta (2013) 0.79
Legume cyclotides shed light on the genetic origin of knotted circular proteins. Proc Natl Acad Sci U S A (2011) 0.76
Dynamic scenario of membrane binding process of kalata b1. PLoS One (2014) 0.76
Peptide and protein-based inhibitors of HIV-1 co-receptors. Exp Biol Med (Maywood) (2013) 0.76
Highly Constrained Bicyclic Scaffolds for the Discovery of Protease-Stable Peptides via mRNA Display. ACS Chem Biol (2017) 0.75
Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach. Chembiochem (2015) 0.75
Design of a MCoTI-Based Cyclotide with Angiotensin (1-7)-Like Activity. Molecules (2016) 0.75
Recombinant Expression of Cyclotides Using Split Inteins. Methods Mol Biol (2017) 0.75
Chemical and biological production of cyclotides. Adv Bot Res (2016) 0.75
The fluorescent toolbox for assessing protein location and function. Science (2006) 14.02
Synthesis of proteins by native chemical ligation. Science (1994) 10.98
Liver transplantation with use of cyclosporin a and prednisone. N Engl J Med (1981) 6.95
Extent of N-terminal methionine excision from Escherichia coli proteins is governed by the side-chain length of the penultimate amino acid. Proc Natl Acad Sci U S A (1989) 4.94
A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated alpha-defensins. Science (1999) 3.90
Chemical synthesis of peptides and proteins. Annu Rev Biochem (1970) 2.78
Production of cyclic peptides and proteins in vivo. Proc Natl Acad Sci U S A (1999) 2.42
Thermal, chemical, and enzymatic stability of the cyclotide kalata B1: the importance of the cyclic cystine knot. Biochemistry (2004) 2.32
Plant cyclotides: A unique family of cyclic and knotted proteins that defines the cyclic cystine knot structural motif. J Mol Biol (1999) 2.29
Biosynthesis and insecticidal properties of plant cyclotides: the cyclic knotted proteins from Oldenlandia affinis. Proc Natl Acad Sci U S A (2001) 2.05
An efficient Fmoc-SPPS approach for the generation of thioester peptide precursors for use in native chemical ligation. Angew Chem Int Ed Engl (2008) 1.95
The chemistry and enzymology of the type I signal peptidases. Protein Sci (1997) 1.90
An unusual structural motif of antimicrobial peptides containing end-to-end macrocycle and cystine-knot disulfides. Proc Natl Acad Sci U S A (1999) 1.87
CyBase: a database of cyclic protein sequences and structures, with applications in protein discovery and engineering. Nucleic Acids Res (2007) 1.86
An asparaginyl endopeptidase mediates in vivo protein backbone cyclization. J Biol Chem (2007) 1.77
Purification of proteins fused to either the amino or carboxy terminus of the Mycobacterium xenopi gyrase A intein. Biotechniques (1999) 1.72
Squash trypsin inhibitors from Momordica cochinchinensis exhibit an atypical macrocyclic structure. Biochemistry (2000) 1.69
Elucidation of the primary and three-dimensional structure of the uterotonic polypeptide kalata B1. Biochemistry (1995) 1.61
Theta-defensins prevent HIV-1 Env-mediated fusion by binding gp41 and blocking 6-helix bundle formation. J Biol Chem (2006) 1.54
Crystal structure of a bacterial signal peptidase apoenzyme: implications for signal peptide binding and the Ser-Lys dyad mechanism. J Biol Chem (2001) 1.51
Ubiquitin fusion technique and related methods. Methods Enzymol (2005) 1.48
Twists, knots, and rings in proteins. Structural definition of the cyclotide framework. J Biol Chem (2002) 1.46
The leucine zipper domain controls the orientation of AP-1 in the NFAT.AP-1.DNA complex. Chem Biol (1996) 1.44
Circular proteins in plants: solution structure of a novel macrocyclic trypsin inhibitor from Momordica cochinchinensis. J Biol Chem (2001) 1.43
Protein expression using cotranslational fusion and cleavage of ubiquitin. Mutagenesis of the glutathione-binding site of human Pi class glutathione S-transferase. J Biol Chem (1994) 1.43
Cyclopsychotride A, a biologically active, 31-residue cyclic peptide isolated from Psychotria longipes. J Nat Prod (1994) 1.40
The cyclotide family of circular miniproteins: nature's combinatorial peptide template. Biopolymers (2006) 1.39
Biosynthesis of circular proteins in plants. Plant J (2007) 1.39
Structural plasticity of the cyclic-cystine-knot framework: implications for biological activity and drug design. Biochem J (2006) 1.35
Chemical synthesis and folding pathways of large cyclic polypeptides: studies of the cystine knot polypeptide kalata B1. Biochemistry (1999) 1.34
Cyclotides: a novel type of cytotoxic agents. Mol Cancer Ther (2002) 1.32
Split-intein mediated circular ligation used in the synthesis of cyclic peptide libraries in E. coli. Nat Protoc (2007) 1.31
Cyclotides as templates in drug design. Drug Discov Today (2009) 1.31
Circular beta-lactamase: stability enhancement by cyclizing the backbone. FEBS Lett (1999) 1.30
The in vitro ligation of bacterially expressed proteins using an intein from Methanobacterium thermoautotrophicum. J Biol Chem (1999) 1.29
Biosynthesis of the cyclotide Kalata B1 by using protein splicing. Angew Chem Int Ed Engl (2006) 1.29
Chemical ligation of unprotected peptides directly from a solid support. J Pept Res (1998) 1.28
Discovery, structure and biological activities of cyclotides. Adv Drug Deliv Rev (2009) 1.26
Biosynthesis of a fully functional cyclotide inside living bacterial cells. Chembiochem (2007) 1.25
Retrocyclins kill bacilli and germinating spores of Bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem (2006) 1.25
Isolation, solution structure, and insecticidal activity of kalata B2, a circular protein with a twist: do Möbius strips exist in nature? Biochemistry (2005) 1.24
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. Chembiochem (2009) 1.24
Chemical and biomimetic total syntheses of natural and engineered MCoTI cyclotides. Org Biomol Chem (2008) 1.24
Alanine scanning mutagenesis of the prototypic cyclotide reveals a cluster of residues essential for bioactivity. J Biol Chem (2008) 1.24
Intracellular protein interaction mapping with FRET hybrids. Proc Natl Acad Sci U S A (2006) 1.24
On the effect of a polypeptide isolated from "Kalata-Kalata" (Oldenlandia affinis DC) on the oestrogen dominated uterus. Acta Pharmacol Toxicol (Copenh) (1973) 1.23
Protein splicing and its applications. Curr Opin Biotechnol (2000) 1.23
Oldenlandia affinis (R&S) DC. A plant containing uteroactive peptides used in African traditional medicine. J Ethnopharmacol (2000) 1.23
Inhibition of HIV budding by a genetically selected cyclic peptide targeting the Gag-TSG101 interaction. ACS Chem Biol (2008) 1.23
Biological diversity and therapeutic potential of natural and engineered cystine knot miniproteins. Curr Opin Pharmacol (2009) 1.21
Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors. Curr Pharm Des (2010) 1.20
Cyclotides: natural, circular plant peptides that possess significant activity against gastrointestinal nematode parasites of sheep. Biochemistry (2008) 1.18
Cytotoxic cyclotides from Viola tricolor. J Nat Prod (2004) 1.18
Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J Med Chem (2008) 1.17
New methods for proteomic research: preparation of proteins with N-terminal cysteines for labeling and conjugation. Angew Chem Int Ed Engl (2002) 1.14
The cyclic cystine knot miniprotein MCoTI-II is internalized into cells by macropinocytosis. Int J Biochem Cell Biol (2007) 1.13
Oxytocic principles of Oldenlandia affinis. Lloydia (1973) 1.12
Lysine-scanning mutagenesis reveals an amendable face of the cyclotide kalata B1 for the optimization of nematocidal activity. J Biol Chem (2010) 1.09
Conformation and mode of membrane interaction in cyclotides. Spatial structure of kalata B1 bound to a dodecylphosphocholine micelle. FEBS J (2006) 1.09
Studies on the membrane interactions of the cyclotides kalata B1 and kalata B6 on model membrane systems by surface plasmon resonance. Anal Biochem (2005) 1.07
The role of the cyclic peptide backbone in the anti-HIV activity of the cyclotide kalata B1. FEBS Lett (2004) 1.07
Structural requirements for the biosynthesis of backbone cyclic peptide libraries. Chem Biol (2001) 1.07
Anti-HIV cyclotides from the Chinese medicinal herb Viola yedoensis. J Nat Prod (2007) 1.06
Potent inhibitors of beta-tryptase and human leukocyte elastase based on the MCoTI-II scaffold. J Med Chem (2009) 1.06
Cyclotides, a promising molecular scaffold for peptide-based therapeutics. Biopolymers (2010) 1.06
"Splicing up" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides. Adv Drug Deliv Rev (2009) 1.06
In vivo biosynthesis of an Ala-scan library based on the cyclic peptide SFTI-1. Amino Acids (2009) 1.05
Backbone cyclised peptides from plants show molluscicidal activity against the rice pest Pomacea canaliculata (golden apple snail). J Agric Food Chem (2008) 1.05
Combined X-ray and NMR analysis of the stability of the cyclotide cystine knot fold that underpins its insecticidal activity and potential use as a drug scaffold. J Biol Chem (2009) 1.05
Inhibition of platelet aggregation by grafting RGD and KGD sequences on the structural scaffold of small disulfide-rich proteins. Platelets (2006) 1.05
Retrovirally delivered random cyclic Peptide libraries yield inhibitors of interleukin-4 signaling in human B cells. J Biol Chem (2002) 1.04
Seven novel macrocyclic polypeptides from Viola arvensis. J Nat Prod (1999) 1.04
Gramicidin S and polymyxins: the revival of cationic cyclic peptide antibiotics. Cell Mol Life Sci (2009) 1.04
Key role of glutamic acid for the cytotoxic activity of the cyclotide cycloviolacin O2. Cell Mol Life Sci (2006) 1.04
Daptomycin. J Infect (2007) 1.03
Isolation, synthesis, and antimicrobial activities of naturally occurring theta-defensin isoforms from baboon leukocytes. Infect Immun (2008) 1.03
Cyclic and acyclic defensins inhibit human immunodeficiency virus type-1 replication by different mechanisms. PLoS One (2010) 1.03
Fmoc-based synthesis of peptide alpha-thioesters using an aryl hydrazine support. J Org Chem (2004) 1.00
Discovery of antibacterial cyclic peptides that inhibit the ClpXP protease. Protein Sci (2007) 1.00
The anthelmintic activity of the cyclotides: natural variants with enhanced activity. Chembiochem (2008) 0.97
Synthesis of proteins by native chemical ligation using Fmoc-based chemistry. Protein Pept Lett (2005) 0.97
A biomimetic strategy in the synthesis and fragmentation of cyclic protein. Protein Sci (1998) 0.95
Peptide chemical ligation inside living cells: in vivo generation of a circular protein domain. Bioorg Med Chem (2001) 0.93
Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease. Anal Biochem (2007) 0.92
Divalent cation coordination and mode of membrane interaction in cyclotides: NMR spatial structure of ternary complex Kalata B7/Mn2+/DPC micelle. J Inorg Biochem (2008) 0.91
Total synthesis of the macrocyclic cysteine knot microprotein MCoTI-II. Chem Commun (Camb) (2006) 0.91
Use of inteins for the in vivo production of stable cyclic peptide libraries in E. coli. Methods Mol Biol (2003) 0.91
Isolation and characterization of novel cyclotides from Viola hederaceae: solution structure and anti-HIV activity of vhl-1, a leaf-specific expressed cyclotide. J Biol Chem (2005) 0.90
Cyclic peptides from Oldenlandia affinis DC. Molecular and biological properties. Chem Biodivers (2008) 0.90
Post-translational peptide bond formation during concanavalin A processing in vitro. Biochem J (1996) 0.89
Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. Chembiochem (2008) 0.89
Biosynthetic phage display: a novel protein engineering tool combining chemical and genetic diversity. Chem Biol (2000) 0.87
Sunflower trypsin inhibitor-1. Curr Protein Pept Sci (2004) 0.86
Expressed protein ligation using an N-terminal cysteine containing fragment generated in vivo from a pelB fusion protein. Protein Expr Purif (2007) 0.86
Circling the enemy: cyclic proteins in plant defence. Trends Plant Sci (2009) 0.85
Cycloviolacin H4, a hydrophobic cyclotide from Viola hederaceae. J Nat Prod (2006) 0.85
N-terminal cysteinyl proteins can be prepared using thrombin cleavage. FEBS Lett (2008) 0.84
The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry (2008) 0.84
Expression of atrial natriuretic factor as a cleavable fusion protein with chloramphenicol acetyltransferase in Escherichia coli. Eur J Biochem (1988) 0.76
Ribosomally synthesized and post-translationally modified peptide natural products: overview and recommendations for a universal nomenclature. Nat Prod Rep (2013) 5.38
Biosynthesis of the cyclotide Kalata B1 by using protein splicing. Angew Chem Int Ed Engl (2006) 1.29
Biosynthesis and biological screening of a genetically encoded library based on the cyclotide MCoTI-I. Chembiochem (2009) 1.24
Motion of a DNA sliding clamp observed by single molecule fluorescence spectroscopy. J Biol Chem (2008) 1.14
Design of a novel cyclotide-based CXCR4 antagonist with anti-human immunodeficiency virus (HIV)-1 activity. J Med Chem (2012) 1.10
Selective immobilization of proteins onto solid supports through split-intein-mediated protein trans-splicing. Angew Chem Int Ed Engl (2006) 1.09
Cyclotides, a novel ultrastable polypeptide scaffold for drug discovery. Curr Pharm Des (2011) 1.08
Cellular uptake of cyclotide MCoTI-I follows multiple endocytic pathways. J Control Release (2011) 1.08
Backbone dynamics of cyclotide MCoTI-I free and complexed with trypsin. Angew Chem Int Ed Engl (2010) 1.07
Cyclotides, a promising molecular scaffold for peptide-based therapeutics. Biopolymers (2010) 1.06
"Splicing up" drug discovery. Cell-based expression and screening of genetically-encoded libraries of backbone-cyclized polypeptides. Adv Drug Deliv Rev (2009) 1.06
In vivo biosynthesis of an Ala-scan library based on the cyclic peptide SFTI-1. Amino Acids (2009) 1.05
Biological synthesis of circular polypeptides. J Biol Chem (2012) 1.03
Protein microarrays: novel developments and applications. Pharm Res (2010) 1.00
In-cell fluorescence activation and labeling of proteins mediated by FRET-quenched split inteins. J Am Chem Soc (2012) 0.95
Expressed protein ligation: a resourceful tool to study protein structure and function. Cell Mol Life Sci (2009) 0.94
Expression of fluorescent cyclotides using protein trans-splicing for easy monitoring of cyclotide-protein interactions. Angew Chem Int Ed Engl (2013) 0.94
Development of a cell-based fluorescence resonance energy transfer reporter for Bacillus anthracis lethal factor protease. Anal Biochem (2007) 0.92
Fabrication of assembled virus nanostructures on templates of chemoselective linkers formed by scanning probe nanolithography. J Am Chem Soc (2003) 0.92
Correlation spectroscopy of minor fluorescent species: signal purification and distribution analysis. Biophys J (2006) 0.90
Photomodulation of protein trans-splicing through backbone photocaging of the DnaE split intein. Chembiochem (2010) 0.89
Recombinant production of rhesus θ-defensin-1 (RTD-1) using a bacterial expression system. Mol Biosyst (2012) 0.85
Biosynthesis and antimicrobial evaluation of backbone-cyclized α-defensins. Biochemistry (2011) 0.84
Expressed protein ligation: a new tool for the biosynthesis of cyclic polypeptides. Protein Pept Lett (2005) 0.80
Efficient one-pot cyclization/folding of Rhesus θ-defensin-1 (RTD-1). Bioorg Med Chem Lett (2012) 0.79
Recombinant expression of backbone-cyclized polypeptides. Biopolymers (2013) 0.78
Applications of functional protein microarrays: identifying protein-protein interactions in an array format. Methods Mol Biol (2007) 0.78
Preparation of peptide p-nitroanilides using an aryl hydrazine resin. Org Lett (2004) 0.76
Insights into the molecular flexibility of θ-defensins by NMR relaxation analysis. J Phys Chem B (2014) 0.76
Rapid parallel synthesis of bioactive folded cyclotides by using a tea-bag approach. Chembiochem (2015) 0.75
Full Sequence Amino Acid Scanning of θ-Defensin RTD-1 Yields a Potent Anthrax Lethal Factor Protease Inhibitor. J Med Chem (2017) 0.75
Novel peptide-based scaffolds for drug discovery. Curr Pharm Des (2011) 0.75